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Summary: Enhanced serum IgA concentrations are common in alcoholic liver cirrhosis, but functional differences
between IgA subclasses and their relation with interleukin-6 (IL-6) have not been described. Distinct immunoregula-
tory mechanisms may exist that selectively affect one subclass. This possibility prompted us to investigate the
distribution of IgAl and IgA2 subclasses in the serum of 25 heavy alcohol drinkers (alcohol: 80 to 200 g per day)
without clinical disorders, in comparison with 35 patients affected by alcoholic liver cirrhosis, 29 viral hepatitis
patients and 33 social drinkers as a control group. Mean (± SD) IgA2 concentration (0.56 ± 0.31 g/1) was signifi-
cantly increased (p < 0.01) in heavy alcohol drinkers, with an IgA2/IgAl ratio of 0.33 ± 0.12, while the mean
total IgA concentration was similar to the control group. Mean IgAl and IgA2 concentrations were significantly
increased (p < 0.001) in alcoholic liver cirrhosis patients (6.13 ± 4.52 g/1 and 1.83 ± 1.93 g/1 respectively, with an
IgA2/IgAl ratio of 0.32 ± 0.19) and viral hepatitis patients (3.66 ± 2.59 g/1 and 0.69 ± 0.67 g/1 respectively, with
an IgA2/IgAl ratio of 0.21 ±0.14) High serum IL-6 concentrations (34 ± 33 ng/1) were correlated with elevated
IgAl and IgA2 concentrations only in patients with alcoholic liver cirrhosis. IgA2 subclass and IgA2/IgAl ratio
could therefore be used as markers of chronic alcohol abuse directly related to the extent and duration of the alcohol
abuse and the effectiveness of alcohol withdrawal.
Introduction 6) peripheral blood monoclonal cells have been reported
Abnormalities in the immune systems of alcoholic liver in Patients with alcoholic liver cirrhosis <10)· IL'6 ΡΓΟ'
cirrhosis patients have been described (1 -4). However, duction Correlates closely with IgA serum levels. This
their pathogenic significance and clinical implications abnormality may be related to overproduction of IgA
remain unknown. Hypergammaglobulinaemia, mainly and i™™6 disturbances in patients with alcoholic
enhancement of the serum IgA concentration, is a com- r dlsease·
mon immunological finding in patients with alcoholic We have studied serum IgA, IgAl, IgA2 and IL-6 con-
liver cirrhosis (5-7). It has been demonstrated that this centrations in heavy alcohol drinkers without clinical
high immunoglobulin concentration is not due to abnor- liver disease in comparison with alcoholic liver cirrhosis
mal catabolism of IgA (1—2). and viral hepatitis patients to clarify the significance of
SwenOaw et al. have shown in patients with alcoholic the hiSh semm l^A2 concentration in relation to alcohol
liver disease that the IgA2 subclass forms a major sub- consumption,
class component contributing to the continuous pattern
of IgA deposition in hepatic tissues (8). Patients and Methods
Recently, high serum IgA2 concentrations were found in Patients
heavy alcohol drinkers without alcoholic liver cirrhosis ^
 biochemicai hepatic characteristics of the four groups are
(9). This subclass may be a predictive marker for evolu- given in table 1.
tion to alcoholic liver disease. - The control group comprised thirty-three healthy subjects (12
T , ,. . , . , . women and 21 men, mean age ± SD: 42 ± 12 years, range: 24-In addition, increased serum concentrations and in vitro
 56 years) who were sodal ^ ^ (alcohol ingestion < 40 g per
spontaneous or induced production of interleukin-6 (IL- day) with normal hepatic characteristics.
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Tab. 1 Hepatic characteristics (mean ± SD (median)) of the studied population.
Group
Reference values (30 °C)
Control social drinkers
Heavy alcohol drinkers
Alcoholic cirrhosis
Viral hepatitis
n
33
25
35
29
Alanine amino-
transferase (U/l)
4-45
17 ± 16(15)
25 ± 5 (23)
67* ± 80 (55)
106** ±57 (111)
Aspartate amino-
transferase (U/l)
10-45
18 ± 15(13)
20 ± 5 (21)
157** ± 75 (139)
85* ± 69 (75)
γ-Glutamyl-
transferase (U/l)
5-40
21 ±20(18)
55** ± 8 (54)
534** ± 523 (248)
71** ±28(70)
* p < 0.01; ** p < 0.001 vs control social drinkers (U-test of Mann & Whitney).
— Twenty-five heavy alcohol drinkers (10 women and 15 men,
mean age ± SD: 52 ± 10 years, range: 35-70 years) who had
ingested more than 80 g alcohol daily for at least five consecutive
years without clinical or biological signs of liver disease were vol-
unteers for a course of alcohol withdrawal.
— Thirty-five patients (7 woman and 28 men, mean age ± SD: 48
±11 years, range: 31 —74 years) with alcoholic liver cirrhosis were
grouped according to the Child-Pugh classification (11). They were
studied at least two months after cessation of alcohol intake. In all
cases, cirrhosis was due to chronic alcohol ingestion and confirmed
by histology. None of the patients had overt signs of viral hepatic
infection.
— Twenty-nine patients (12 women and 17 men, mean age ± SD:
50 ±15 years, range: 17—71 years) with viral hepatitis B
(n = 13), C (n = 11) and non-A, non-B, non-C (n = 5) were con-
trolled in this study. The hepatitis was diagnosed according to con-
ventional criteria, including serological markers using currently
available assays and liver biochemical test abnormalities (alanine
amino-transferase > 1.5 the upper normal limit for longer than six
months). None of the viral hepatitis patients had liver cirrhosis.
In alcoholic liver cirrhosis and viral hepatitis patients, alcohol in-
gestion was less than 40 g per day at the time of the sample.
All patients gave their informed consent to the experimental proto-
col.
Serum samples
Blood samples were collected in sterile, clean, dry tubes and
rapidly separated after coagulation. Serum was stored at —20 °C.
Measurement of serum IgA, IgAl and IgA2
concentrations
Concentrations of IgA, and IgAl, IgA2 subclasses in serum were
measured by a sandwich time-resolved immunofluorometric assay
as previously described (12—14). The plates for microtitration
(Microwell-Maxisorp™, Nunc, Roskilde, Denmark) were coated
overnight at 4 °C with 200 μΐ of polyclonal anti-human α-chain
(Dako, Glostrup, Denmark), at 0.005 g/1 for IgA and IgAl, and at
0.010 g/1 for IgA2, diluted in 0.05 mol/1 K2HPO4 buffer adjusted
to pH 8.5. Excess binding sites were blocked by three washes with
0.05 mol/1 NaH2PO4 di-hydrate containing 5 g/1 bovine serum albu-
min and 60 g/1 sorbitol. Six serial dilutions of the OSAU standard
(Behring, Marburg, Germany; IgA = 2.45 g/1, IgAl = 2.02 g/1 and
IgA2 = 0.43 g/1) and two dilutions of the tested samples, in 0.1
mol/1 Tris-HCl buffer adjusted to pH 7.75 (added to 0.15 mol/1
NaCl, 5 g/1 bovine serum albumin, 1 g/1 Tween 20 and 0.02 mol/1
di-ethylene-triamino pentacetic acid), were applied in duplicate and
incubated for 2 hours at 20 °C with continuous shaking. After three
washes with 0.05 mol/1 Tris-HCl buffer at pH 7.75 containing 0.25
g/1 Tween 20, 200 μΐ of the following europium-labelled antibodies
(0.00025 g/1) were added for 1 hour at 2 °C with gentle shaking:
anti-human α-chain (Dako), monoclonal IgGlK to human α 1-chain
(clone NI 69-11, Nordimmune™, Nordic, The Netherlands) and
monoclonal IgGlK to human a2-chain (clone NI J 12, Nordimmu-
ne™, Nordic). Two hundred μΐ of the enhancement solution (Wai-
lac, Turku, Finland) were then added for 10 minutes with con-
tinuous shaking to dissociate the europium ions from the labelled
immune complexes, providing highly fluorescent chelates (15).
The fluorescence level was measured after a rest period of 10 min-
utes, using a fluorometer with a xenon flash lamp (1230 Arcus™
Fluorometer, Wallac). The concentrations of IgA, IgAl and IgA2
were calculated by the standard curves.
The reliability of the reagents used in this assay had been pre-
viously verified (specificity 99% for anti-IgAl and 98% for anti-
IgA2; sensitivity 1 μ^Ι for both subclasses; linearity 10—1000 μg/l
for IgAl and 10—400 μg/l for IgA2; intra-assay variations 4.7—
6.1%; inter-assay variations 6.7-9.1%) (12).
Measurement of serum interleukin-6 concentration
Level of IL-6 in serum was measured by means of an enzyme
amplified sensitivity immunoassay, performed on a microtitration
plate (Medgenix, Fleurus, Belgium). It is based on the oligoclonal
system in which several monoclonal antibodies directed against
distinct epitopes of IL-6 are used. The assay was performed di-
rectly on serum without any treatment or extraction. The amount
of substrate (tetramethylbenzidine-H2O2) turnover was determined
colorimetrically by measuring absorbance at 450 mm.
Statistical analysis
Results were expressed as arithmetic mean ± standard deviation
(SD) and median. For the different properties, results were ex-
pressed as frequency (%) in comparison with the normal upper
limit (mean ± 2 SD) of each property obtained for the control so-
cial drinkers. The Mann & Whitney U-test was used to compare
the data from each group versus the control group. For correlation
studies, Spearman's rank correlation was used. Values of p s 0.05
were taken as significant.
Results
The results of the measurement of IgA, IgAl and IgA2
subclasses and IL-6 concentrations are expressed in
table 2 and IgA2/IgAl ratios in figure 1.
Serum IgA, IgAl and IgA2 concentrations
and IgA2/IgAl ratio
In this study, there was no difference in IgA subclass
concentrations and IgA2/IgAl ratios between men and
women in the heavy alcohol drinkers and alcohol liver
cirrhosis patients, even though women are far more
prone to alcohol-induced liver damage.
— In the heavy alcohol drinkers, the IgA concentration
was elevated in 3/25 (12%) of patients; the preva-
lence of elevated concentrations of IgAl, 1/25 (4%)
and IgA2, 7/25 (28%) differed significantly
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Tab. 2 Serum concentration (mean ± SD (median)) of the IgA, IgAl, IgAl and interleukin-6.
Group
Control social drinkers
Heavy alcohol drinkers
Alcoholic cirrhosis
Viral hepatitis
n
33
25
35
29
IgA (g/1)
2.42 ±0.86 (2.31)
2.30 ± 1.30(2.12)
7.61** ±5.29(7.01)
4.45** ± 3.03 (3.47)
IgAl (g/1)
2.18 ± 0.73 (2.27)
1.77* ± 1.03(1.56)
6.13** ±4.52(4.34)
3.66* ± 2.59 (2.60)
IgA2 (g/1)
0.39 ± 0.34 (0.28)
0.56** ± 0.31 (0.55)
1.83*** ± 1.93(1.20)
0.69* ± 0.67 (0.45)
IL-6 (ng/1)
3.8 ± 1.9(3)
4 ± 1.9(3)
34*** ± 33 (22)
150* ±322(12)
p < 0.05; ** p < 0.01; *** p < 0.001 vs control social drinkers (U-test of Mann & Whitney).
Viral
hepatitis
(n=29)
Fig. 1 IgA2/IgAl ratio (mean ± SD) in control drinkers, in heavy
drinkers, and in patients with liver disease.
* p < 0.01; ** p < 0.001 vs control drinkers (U-test of Mann &
Whitney).
Correlations between serum IgA, IgAl and
IgA2, and interleukin-6 concentrations
In the heavy alcohol drinkers, IgAl and IgA2 concentra-
tions were positively correlated (p < 0.01). In contrast,
in alcohol liver cirrhosis and viral hepatitis patients, the
elevated IgAl and IgA2 serum concentrations were in-
versely correlated. In patients with alcoholic liver cir-
rhosis, a significant positive correlation (p < 0.01) was
observed between elevated IgAl and IgA2 concentra-
tions and IL-6 secretion.
Discussion
The reliability criteria for the time-resolved immunoflu-
orometric assay used for the measurement of total IgA
and IgAl, and IgA2 subclasses were very satisfactory.
This non-isotopic method is simple to perform and its
high sensitivity makes it suitable for the determination
of serum IgAl and IgA2 concentrations in patients with
alcoholic liver disease.
(p < 0.01), with a predominance of IgA2. The IgA2/
IgAl ratio was elevated in 8/25 of patients (32%).
— In alcohol liver cirrhosis patients, the IgA concentra-
tion was elevated in 22/35 patients (63%); the preva-
lence of the elevated concentrations did not differ
between IgAl, 20/35 (57%) and IgA2 22/35 (63%).
The IgA2/IgAl ratio was elevated in 9/35 patients
(26%).
— In viral hepatitis patients, the IgA concentration was
elevated in 12/29 patients (41%), the prevalence of
elevated concentrations of IgAl, 11/29 (38%) and
IgA2 5/29 (17%) differed significantly (p <0.01),
with a predominance of IgAl. The IgA2/IgAl ratio
was elevated in 3/29 patients (10%).
Serum concentration of interleukin-6
Mean IL-6 concentration was significantly increased in
patients with alcohol liver cirrhosis (p < 0.001) and in
viral hepatitis patients (p < 0.05). In this last group,
there was a wide range of values (3 — 1230 ng/1). In these
two groups, the prevalence of elevated concentrations of
IL-6 was 10/17 (59%) and 12/23 (52%) respectively, and
did not significantly differ.
Heavy alcohol drinkers and alcoholic
cirrhosis patients
In the heavy alcohol drinkers and the alcoholic liver cir-
rhosis patients, in whom the alcohol factor was present,
the study showed an increased IgA2/IgAl ratio. What-
ever the total IgA concentration, the ratios in the heavy
drinkers and alcoholic cirrhosis patients (0.33 ± 0.12
and 0.32 ±0.19, respectively) were significantly dif-
ferent from the control social drinkers and the viral hep-
atitis patients. This agrees with our previous studies in
which serum IgA subclass distributions were anlyzed in
alcohol liver disease (9). The increase in IgA2/IgAl ra-
tio could constitute a diagnostic or predictive marker in
heavy alcohol drinkers (prevalence: 32%) evolving to
cirrhosis (26%), while this prevalence in viral hepatitis
patients is 10%. In heavy alcoholic drinkers without
clinical liver disease, microvascular changes in the in-
testinal tract may be considered as the cause of the
plasma protein loss into the jejunal lumen demonstrated
by Buell & Beck, and Ray et al. in the dog (16, 17).
Several studies have shown the direct toxic effects of
alcohol on intestinal epithelial cells and hepatocytes (18,
19). In particular, loss of superficial cells and damage to
the upper layer of mucosa can be observed in the intesti-
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nal epithelium (20). These morphological changes in the
small bowel epithelium are found even in the absence
of cirrhosis (21). Alcohol increases intestinal permeabil-
ity to macromolecules whatever the degree of hepatic
dysfunction (22). The primary effect of alcohol may be
the release of pro-inflammatory mediators such as ru-
mour necrosis factor- and IL-6 that can increase intesti-
nal permeability and local immunoglobulin secretion.
Seilies et al. observed too that serum secretory IgA and
free secretory component concentrations were signifi-
cantly increased in patients with chronic alcoholic liver
disease, even at a very early stage of the disease, and
decreased after alcohol withdrawal (23).
Alcoholic liver cirrhosis patients
In alcoholic liver cirrhosis patients, the observation of
an increase in both serum IgAl and IgA2 concentrations
with frequencies of 57% and 67% respectively, as well
as the positive correlation with IL-6 concentration,
seems to be a major abnormality due to an immune re-
sponse against many intestinal antigens and cytokine
production. IL-6 is responsible for subsequent activation
of B cells, resulting in their differentiation into IgA-se-
creting plasma cells.
The marked increase in total serum IgA concentrations
in patients with cirrhosis could be due to a secondary
effect of the initial release of free secretory component/
secretory IgA to the plasma compartment, leading to ab-
normalities in cytokine regulation (24—26). In addition,
the abnormal permeability of the intestinal barrier in al-
coholic liver cirrhosis patients could allow an increased
antigenic load in the plasma as food antigens and lipo-
polysaccharide (27). Increased IgA synthesis may reflect
this increased antigenic load and the diminished T-cell
suppression, or T-cell independent B-cell stimulation (8,
28). The IgA2 antibodies also have lipopolysaccharide
and other amphiphilic components of Gram-negative
bacteria as targets (29—30). Moreover, peripheral blood
mononuclear cells from patients with alcoholic liver cir-
rhosis show an increased lipopolysaccharide-induced
IL-6 secretion, which has been correlated with increased
IgA serum concentrations (10, 26).
Recently, Guillemin et al. have shown that IgA faecal
output was increased in alcoholic liver cirrhosis patients
in comparison with control social drinkers (31). This ob-
servation confirms the possible role of the gut-associated
lymphoid tissue in the serum IgA subclass metabolism.
Intestinal IgA synthesis may be stimulated in alcohol
liver cirrhosis patients and could help explain the serum
IgA2 subclass origin also. This IgA2 subclass formed
the major subclass contributing to the continuous pattern
of IgA deposition in hepatic tissues (8). The role of this
subclass seems very important in the extent of the liver
damage and its serum increase may be related to alcohol
consumption.
Viral hepatitis patients
In viral hepatitis patients, while there is an increase in
serum IgA2 subclass, the absence of any difference in
the IgA2/IgAl ratio from the control social drinkers sug-
gests that the IgA metabolism is different in heavy alco-
hol drinkers and alcoholic liver cirrhosis patients. The
pro-inflammatory cytokines (IL-6) induce IgA secretion
in both subclasses. The lower significance of the serum
IL-6 increase in viral hepatitis patients than in alcoholic
liver cirrhosis patients may be explained by the marked
heterogeneity of this group (nature of the virus, severity
of the infection). In fact, in viral hepatitis patients, there
are probably only slight disturbances in the intestinal
permeability, but the IgA metabolism seems to be pro-
foundly disturbed.
Conclusion
The measurement of serum IgA sbuclasses and IgA2/
IgAl ratio in patients with either normal or elevated se-
rum total IgA could provide a means to detect alcoholic
liver patients that are heavy alcoholic drinkers or viral
hepatitis patients evolving to clinical complications such
as cirrhosis or damage to the gastro-intestinal tract. In
these situations, the IgA2 subclass, and the IgA2/IgAl
ratio in particular, could be specific markers of chronic
alcohol abuse directly related to the extent and duration
of the alcohol abuse. However, further studies are re-
quired to confirm this, including a longitudinal study in
heavy drinkers evolving to cirrhosis.
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